Peer Reviewed
Gastroenterology clinic
Screening, investigating and managing haemochromatosis
Abstract
Usually developing in patients aged between 30 and 60 years, haemochromatosis can lead to severe systemic complications if untreated. Here, Dr Watson outlines his approach to this condition.
Key Points
- Hereditary haemochromatosis is the most common inherited disease in Australia in people of Northern European descent. It is characterised by the deposition in various organs of excess iron (in the form of the iron-protein compound haemosiderin, formed by the polymerisation of ferritin). This leads to eventual fibrosis and functional organ failure.
- Great advances have been made in recent years in our understanding of the genetics of hereditary haemochromatosis, and it is now recognised as a common phenotype resulting from mutations in at least five unique genes.
Remember
Get full access
Buy this article
Single article purchases are temporarily unavailable due to site maintenance.
If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.
Thank you for your patience and understanding.
Already a subscriber? Login here.